skip to content

At-a-Glance

Issue No. 32 | August 1, 2008

News and Features

Updated Pediatric Treatment Guidelines Now Available

AIDSinfo is proud to announce that the latest update to the Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection has been released. The new version includes updated information on:

  • Recommended antiretroviral regimens for initial therapy
  • Nelfinavir, which now meets FDA limits for ethyl methane sulfonate (EMS)

The changes are highlighted in yellow throughout the text and tables. The updated guidelines are available for download from the Pediatric Guidelines section of the AIDSinfo Web site. You can also request to receive them by mail or email from the AIDSinfo Order Publications section.

Your Feedback Is Important!

The Pediatric Antiretroviral Guidelines Working Group would like to hear your feedback on the latest revisions to the Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection. Please send your comments with the subject line "Pediatric Comments" to AIDSinfoWebmaster@aidsinfo.nih.gov by August 15, 2008.

NIH: Imaging Techniques Yield New Information on How HIV Infects Cells and Provides Clues to Vaccine Design

"The use of advanced imaging techniques has allowed researchers to visualize how a key part of the human immunodeficiency virus (HIV) changes shape after binding to immune system cells or to infection-fighting antibodies."

For more information, read the full NIH press release.